India bans OTC sales of cough syrups, making prescriptions mandatory. Rs 5,700 crore market may see volume decline and slower pharma growth, says report.

To be sure, monitoring is lax, and even Schedule H drugs, which can only be sold on prescription, are freely available across the counter at pharmacies | India News

The Centre has tightened its norms on cough syrups, banning over-the-counter (OTC) sale of the product without a doctor’s prescription, the Union Health Ministry said in its…

Indian syrups have been linked to deaths of children at home and abroad